Sorry, we don't support IE.

We see that you are using Internet Explorer, an old and unsafe browser. Because of this we can not show you the website that we want you to see.

Please come back in a different browser like Chrome, Firefox or Microsoft Edge. We will be right here, see you in a minute!

Topcon Healthcare unveils GAIA and Maestro3 series powered by IMAGEnet®7, MYAH PRO, Clinical Decision Support Solutions for Glaucoma, and a new Patient-Guided Refraction System at the ESCRS 2026 in London

Published on

Capelle aan den IJssel, The Netherlands — September 2,  2026: Topcon Healthcare, a global leader in diagnostic devices and digital healthcare solutions for eye care, is pleased to announce six innovations that will be unveiled at the congress of the European Society of Cataract and Refractive Surgery, which will take place at ExCeL London from September 11-15, 2026.

Designed around the needs of today's eye care professionals, the Topcon Healthcare stand at the ESCRS brings together retina, glaucoma, anterior segment, and refraction solutions within a connected ecosystem that links diagnostics, digital health, and clinical collaboration.

  • GAIA, a fully automated ultra-widefield retinal imaging device offering a 209°1 field of view in a single capture, is designed to deliver true-colour ultra-widefield fundus imaging with exceptional ease. It offers automated alignment, non-contact, non-mydriatic operation in a compact, user-friendly platform.
  • Maestro3 series offers faster acquisition of OCT and OCTA², delivering 130,000 A-scans per second, in addition to slit-scanning technology that delivers high-quality fundus images through pupils as small as 2.0 mm, automated alignment and capture, the new ONEscanTM protocol, which delivers more data in less time with just one touch. Maestro3 Plus offers FAF photography, providing a noninvasive view of retinal metabolic health through high-contrast visualization of RPE autofluorescence4,5.
  • MYAH PRO enables an integrated diagnostic platform designed to support eye care professionals across a range of clinical pathways, including myopia management, Ortho-K, ocular surface assessment, premium IOL planning, and pre-surgical assessment.
  • The new Patient-Guided Refraction System is a compact hub for modern refraction, combining advanced automation, intuitive controls, and seamless workflow integration in one flexible system.
  • New Glaucoma Module for IMAGEnet7 Ver.2.00.
  •  Harmony Ver. 3.12 Connected Care Cloud Platform with Clinical Decision Support for Early Detection of Glaucoma.

“The unveiling of multiple innovative products at the ESCRS 2026 in London represents a major milestone in our product offering for our customers. We are very proud to see the results of several years of product research and development on show at the ESCRS,” says Hideyuki Takizawa, President, Eye Care Business Division, Topcon. He continued, “With these releases, Topcon solidifies its position as a leader in the development of innovative, integrated solutions that improve access and quality of eye care.”

Joe Keenan, Regional President EMEA, expressed that “We are proud to be showcasing six integrated innovations at the ESCRS this year, bringing Topcon Healthcare’s connected eye care ecosystem to life across retina, glaucoma, anterior segment and refraction. Visitors will experience how advanced diagnostics, digital health and clinical decision support come together to support more efficient, data-driven and collaborative care. From GAIA and Maestro3 series for retina and glaucoma, to MYAH PRO for anterior segment applications, the Patient-Guided Refraction System, new clinical decision capabilities in IMAGEnet7, and connected care workflows through Harmony, these innovations demonstrate our vision for the future of eye care.”

Topcon’s new innovations are now available in European markets, with the launch and showcase planned for the 44th European Society of Cataract and Refractive Surgery (ESCRS) from September 11-15, 2026, at ExCeL London, UK.

1- 209° is an estimated value derived from a visual angle of 150° (GAIA), based on the visual-angle-to-eye-angle relationship described in the following article.
Xincheng Yao, Devrim Toslak, Taeyoon Son, Jiechao Ma. Understanding the relationship between visual-angle and eye-angle for reliable determination of the field-of-view in ultra-wide-field fundus photography. Biomedical Optics Express, 2021 Sep 30;12(10):6651-6659
2- Optional 
3- Confirmed with model eye
4-Yung M, Klufas MA, Sarraf D, 2016, Clinical applications of fundus autofluorescence in retinal disease. Int J Retina Vitreous, 2016;2:12. doi:10.1186/s40942-016-0035-x
5-Schmitz-Valckenberg S, Holz FG, 2008, Fundus autofluorescence imaging: do you need it and when? Retinal Physician. 2008;Apr 1.
 

About Topcon Healthcare

Topcon Europe Medical is a company of Topcon Corporation. Our vision is to empower providers with smart, value-driven, and efficient technologies for enhanced care. Keeping pace with the ever-changing healthcare landscape, Topcon offers the latest integrated solutions, including advanced multimodal imaging, vendor-neutral data management, and groundbreaking remote diagnostic technology.

For more information, please visit: https://topconhealthcare.eu/en_EU
 

Media Contacts:

Topcon Healthcare
Mely Medel
Head of Marketing EMEA
[email protected]